Articles from: Healio
AVT04, a biosimilar candidate to ustekinumab developed by Alvotech, met the primary endpoint in a confirmatory clinical study of patients with chronic plaque-type psoriasis,...
-
ICYMI: AVT04, a biosimilar candidate to #ustekinumab developed by Alvotech, met the primary endpoint in a confirmatory clinical study of patients with chronic plaque-type #psoriasis #biosimilar https://t.co/byGrFKvhNo - view on twitter
SAN FRANCISCO — Treatment with inhaled interferon beta failed to improve discharge and recovery in patients hospitalized with moderate COVID-19, according to results of...
-
#ICYMI: Presented at #ATS2022: Inhaled interferon beta failed to improve discharge and recovery in patients hospitalized with moderate #COVID19, but analyses showed trends in favor of progression to severe disease or death https://t.co/MQUxCYfZYi - view on twitter
United Therapeutics Corp. announced that the FDA has approved the Tyvaso dry powder inhaler for the treatment of pulmonary arterial hypertension and pulmonary hypertension...
-
FDA approved inhaled #treprostinil for the treatment of pulmonary arterial hypertension and #pulmonaryhypertension associated interstitial lung disease. More about today’s approval below. https://t.co/IqHxMLO03A - view on twitter
Mashup Score:4
HealioDigestive Disease Week - 9 hours
Mashup Score:4
The latest news from DDW, including perspectives and interviews with leading researchers and...
-
#Micdrop or, in a journalist’s case, recorder drop! That’s a wrap on #DDW2022 ✅, thank you @DDWMeeting for having us! Check out what you missed and stay tuned for more in #GI, #hepatology and #digestivedisease news here: https://t.co/90cc37AHSI #GITwitter #MedTwitter https://t.co/90cc37AHSI - view on twitter
Mashup Score:3
HealioMyositis Awareness Month sheds light on patient voices, disease costs - 9 hours
Mashup Score:3
Myositis Awareness Month is focused on raising awareness and amplifying voices for patients with diseases falling under the myositis umbrella. Earlier in May, the...
-
ICYMI: In recognition of #Myositis Awareness Month, Healio compiled five recent stories touching on topics such as medication interruptions in patients with these — and related — diseases and the monetary costs they carry, even before official diagnoses. https://t.co/3vySF2fI0c - view on twitter
More coverage:
#myositis
Mashup Score:1
HealioThe Latest News and Notes, plus Conversation with Eve J. Higginbotham, SM, MD, ML - 10 hours
Mashup Score:1
May 09, 2022 36 min listen Source/Disclosures Published by: Disclosures: Hovanesian consults widely in the...
-
Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, talk equity in eye care in the latest episode of #Eyeluminaries. Plus, listen to their interview with guest Eve J. Higginbotham, SM, MD, ML. https://t.co/lOxVg8jEme #podcast #eyecare #ophthalmology https://t.co/lOxVg8jEme - view on twitter
Mashup Score:1
HealioCannabinoid use increases need for higher sedation during endoscopy - 10 hours
Mashup Score:1
SAN DIEGO — Baseline cannabinoid use associated with the need for increased sedation among patients who underwent endoscopy with endoscopist-directed conscious sedation, according to...
-
#ICYMI from #DDW2022: “Overall, our findings could suggest that the overall tolerability of outpatient #endoscopy is similar between #cannabinoid users and non-users,” @yasipasi @DDWMeeting #GITwitter #MedTwitter #medicalmarijuana https://t.co/lWuCYd7u65 - view on twitter
First responders to the World Trade Center had higher rates of clonal hematopoiesis-associated mutations than firefighters not exposed to the dust, gases and potential...
-
Study suggests World Trade Center first responders have higher burden of mutations linked to blood cancers Read more here: https://t.co/IyuQzjZ7LX @UVMLarnerMed #MedNews #oncology @NatureMedicine @VUMC_Cancer @UVMLarnerMed @MontefioreNYC @RutgersCancer - view on twitter
-
Study suggests World Trade Center first responders have higher burden of mutations linked to blood cancers Read more here: https://t.co/HuRhAus58z @UVMLarnerMed #MedNews #oncology @NatureMedicine @VUMC_Cancer @UVMLarnerMed @MontefioreNYC @RutgersCancer - view on twitter
Younger patients with diffuse midline glioma experienced prolonged clinical improvement after receiving an investigational chimeric antigen receptor T-cell therapy, study results demonstrated. Updated phase...
-
Younger patients with diffuse midline glioma experienced prolonged clinical improvement after receiving an investigational chimeric antigen receptor T-cell therapy, study results demonstrated. https://t.co/33FHeDebaX @michelle_monje #braincancerawareness #celltherapy - view on twitter
Patients with CVD are 40% to 80% more likely to have comorbid obstructive sleep apnea, which in severe cases can cause them to stop...
ICYMI: "Cardiologists are in a unique position to increase the screening and diagnosis of OSA, getting patients on a treatment pathway that can improve their overall health, well-being and quality of life" @malhotra_md @HealioPulm @healioneurology https://t.co/uyVsn6KB1Z - view on twitter